Related Experiment Videos
The apnea test for brain death determination: an alternative approach
Michael D Sharpe1, G Bryan Young, Chris Harris
1Department of Anesthesia and Perioperative Medicine, University of Western Ontario, London Health Sciences Centre-University Campus, London, Ontario, Canada. michael.sharpe@lhsc.on.ca
Neurocritical Care
|September 22, 2005
Summary
Administering carbon dioxide (CO2) exogenously offers a safe and reliable alternative to the standard apnea test. This method accurately predicts partial pressure of carbon dioxide (PaCO2) levels, avoiding complications associated with the traditional approach.
Area of Science:
- Physiology
- Medical Devices
- Transplantation Medicine
Background:
- The standard apnea test for assessing respiratory function can lead to inaccurate partial pressure of carbon dioxide (PaCO2) levels.
- Overshooting or undershooting target PaCO2 can compromise organ viability for transplantation or invalidate test results.
Purpose of the Study:
- To evaluate an alternative method for the apnea test using exogenously administered CO2.
- To determine the reliability and safety of this novel approach in adult patients.
Main Methods:
- Sixty adult patients underwent an alternative apnea test utilizing externally supplied CO2.
- End-tidal CO2 measurements were taken to predict PaCO2 levels.
Main Results:
- The alternative method successfully achieved adequate respiratory stimulus in all patients, with a mean PaCO2 increase of 28+/-3 mmHg.
- A strong correlation was found between predicted and measured PaCO2 (r=.75169, p<0.0001).
- Minimal complications were observed, including a clinically insignificant reduction in arterial blood pressure.
Conclusions:
- Exogenously administered CO2 is a reliable and safe alternative to the standard apnea test.
- This method presents several advantages over the conventional apnea test, with minimal complications.
- The technique accurately predicts PaCO2, enhancing its utility in clinical settings.